Concepedia

Hui Yang

HY

Statistics

Publications

69

Citations

6K

H-Index

41

Active since

2004

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

Merck & Co., Inc., Rahway, NJ, USA (United States)

Hui Yang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, myelodysplastic syndromes, and oncology.

ORCID

Publications per year

2004–2024

69

Publications

69

Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia

Guillermo Garcia‐Manero, Hagop M. Kantarjian, Blanca Sánchez‐González et al. · Blood · 2006 · 468 citations · Full text

, , +10

Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point

Rachel Darman, Michael Seiler, Anant A. Agrawal et al. · Cell Reports · 2015 · 463 citations · Full text

, , +14

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

Guillermo Garcia‐Manero, Hui Yang, Carlos E. Bueso‐Ramos et al. · Blood · 2007 · 461 citations

, , +16

Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome

Andres O. Soriano, Hui Yang, Stefan Faderl et al. · Blood · 2007 · 388 citations · Full text

, , +15

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

Guillermo Garcia‐Manero, Sarit Assouline, Jörge E. Cortes et al. · Blood · 2008 · 234 citations · Full text

, , +10

1–5 of 69